Fingerprint
Dive into the research topics of 'Pre-clinical study of drug combinations that reduce breast cancer burden due to aberrant mTOR and metabolism promoted by LKB1 loss'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Pre-clinical study of drug combinations that reduce breast cancer burden due to aberrant mTOR and metabolism promoted by LKB1 loss
Rafaela Andrade-Vieira, Donna Goguen, Heidi A. Bentley, Chris V. Bowen, Paola A. Marignani
Research output: Contribution to journal › Article › peer-review
22
Citations
(Scopus)